This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Susan A. Fiscus, PhD; Adaora A. Adimora, MD, MPH; Victor J. Schoenbach, PhD; Wilma Lim, MD; Ross McKinney, MD; David Rupar, MD; Jean Kenny, MD; Charles Woods, MD; Catherine Wilfert, MD

JAMA. 1996;275(19):1483-1488.

Abstract
Objectives.
—To assess health care providers' identification of human immunodeficiency virus (HIV)—exposed infants, to ascertain the prevalence of transplacental or oral zidovudine treatment among infants exposed to HIV, and to estimate the impact of zidovudine use on perinatal transmission in rural and urban North Carolina.

Design.
—Survey of North Carolina newborns tested for HIV infection in 1993 and 1994 compared with the number of anonymous HIV-positive childbearing women.

Setting.
—North Carolina hospitals, public health clinics, and private physicians' offices.

Main Outcome Measures.
—Rates of identification of HIV-exposed infants and of perinatal HIV-1 transmission, determined by HIV culture and polymerase chain reaction testing in the infants.

Results.
—The proportion of HIV-exposed children in North Carolina who were identified and tested increased from 60% in 1993 to 82% for all of 1994, and to more than 90% for the last quarter of 1994. The HIV-exposed infants born in rural counties were more likely to be recognized than those born in urban counties (P<.001). In 1994, most infants were evaluated relatively early in life: 39% by 1 week of age, 63% by 6 weeks, and 76% by 3 months. Among infants with recognized HIV exposure, transmission decreased significantly between 1993 and 1994, from 21% to 8.5%, respectively (P=.009). After the announcement of the results of AIDS Clinical Trials Group Protocol 076, zidovudine was given to 75% of HIV-positive women who delivered infants in North Carolina. Only 5.7% of infants who received any zidovudine became infected, compared with 18.9% of infants who received no zidovudine (P=.007).

Conclusions.
—Health care providers in North Carolina are identifying most of the state's HIV-seropositive pregnant women, treating them with zidovudine, and testing their infants soon after birth for HIV infection. The use of zidovudine in pregnant women and their infants has reduced perinatal HIV transmission in the state.

(JAMA. 1996;275:1483-1488)

Author Affiliations
From the Departments of Microbiology and Immunology (Dr Fiscus), Medicine (Dr Adimora), Epidemiology (Dr Schoenbach), and Pediatrics (Dr Lim), University of North Carolina at Chapel Hill; Departments of Pediatrics (Drs McKinney and Wilfert) and Microbiology and Immunology (Dr Wilfert), Duke University Medical Center, Durham, NC; Department of Pediatrics, Carolinas Medical Center, Charlotte, NC (Dr Rupar); Department of Pediatrics, East Carolina University School of Medicine, Greenville, NC (Dr Kenny); and Department of Pediatrics, Bowman-Gray Medical School, Winston-Salem, NC (Dr Woods).

Footnotes
Reprints: Susan A. Fiscus, PhD, CB 7140, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ultrasensitive p24 Antigen Assay for Diagnosis of Perinatal Human Immunodeficiency Virus Type 1 Infection
Fiscus et al.
J. Clin. Microbiol. 2007;45:2274-2277.
ABSTRACT | FULL TEXT  

HIV Infection and Zidovudine Use in Childbearing Women
Sia et al.
Pediatrics 2004;114:e707-e712.
ABSTRACT | FULL TEXT  

Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1
Mandelbrot et al.
JAMA 2001;285:2083-2093.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Universal Compared With Voluntary Screening for Human Immunodeficiency Virus Among Pregnant Women in Chicago
Immergluck et al.
Pediatrics 2000;105:54e-54.
ABSTRACT | FULL TEXT  

Trends in Perinatal Transmission of HIV/AIDS in the United States
Lindegren et al.
JAMA 1999;282:531-538.
ABSTRACT | FULL TEXT  

Maternal Levels of Plasma Human Immunodeficiency Virus Type 1 RNA and the Risk of Perinatal Transmission
Garcia et al.
NEJM 1999;341:394-402.
ABSTRACT | FULL TEXT  

Translating Clinical Trial Results into Practice: The Effect of an AIDS Clinical Trial on Prescribed Antiretroviral Therapy for HIV-Infected Pregnant Women
Turner et al.
ANN INTERN MED 1999;130:979-986.
ABSTRACT | FULL TEXT  

Prophylactic Cesarean Delivery for the Prevention of Perinatal Human Immunodeficiency Virus Transmission: The Case for Restraint
Stringer et al.
JAMA 1999;281:1946-1949.
FULL TEXT  

Lack of Long-term Effects of In Utero Exposure to Zidovudine Among Uninfected Children Born to HIV-Infected Women
Culnane et al.
JAMA 1999;281:151-157.
ABSTRACT | FULL TEXT  

Prevention and Treatment of Pediatric HIV Infection
Luzuriaga and Sullivan
JAMA 1998;280:17-18.
FULL TEXT  

Perinatal HIV-1 Transmission: Interaction Between Zidovudine Prophylaxis and Mode of Delivery in the French Perinatal Cohort
Mandelbrot et al.
JAMA 1998;280:55-60.
ABSTRACT | FULL TEXT  

The Case for Rapid HIV Testing During Labor
Minkoff and O'Sullivan
JAMA 1998;279:1743-1744.
FULL TEXT  

HIV Infection and AIDS in the Public Health and Health Care Systems: The Role of Law and Litigation
Gostin and Webber
JAMA 1998;279:1108-1113.
ABSTRACT | FULL TEXT  

Ethics of Placebo-Controlled Trials of Zidovudine to Prevent the Perinatal Transmission of HIV in the Third World
Merson et al.
NEJM 1998;338:836-841.
FULL TEXT  

Surveillance of Pediatric HIV Infection
Committee on Pediatric AIDS
Pediatrics 1998;101:315-319.
ABSTRACT | FULL TEXT  

Factors affecting uptake of antenatal HIV testing in London: results of a multicentre study
Gibb et al.
BMJ 1998;316:259-261.
ABSTRACT | FULL TEXT  

From exceptionalism to normalisation: a reappraisal of attitudes and practice around HIV testing
De Cock and Johnson
BMJ 1998;316:290-293.
FULL TEXT  

Treating the HIV-Infected Pregnant Woman and Her Child
AIDS Clin Care 1997;1997:1-1.
FULL TEXT  

National HIV Case Reporting for the United States -- A Defining Moment in the History of the Epidemic
Gostin et al.
NEJM 1997;337:1162-1167.
FULL TEXT  

Unethical Trials of Interventions to Reduce Perinatal Transmission of the Human Immunodeficiency Virus in Developing Countries
Lurie and Wolfe
NEJM 1997;337:853-856.
FULL TEXT  

Antiretroviral Therapy for HIV Infection in 1997: Updated Recommendations of the International AIDS Society--USA Panel
Carpenter et al.
JAMA 1997;277:1962-1969.
ABSTRACT  

Infectious Diseases
JAMA 1997;277:1865-1866.
 

Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
Sperling et al.
NEJM 1996;335:1621-1629.
ABSTRACT | FULL TEXT  

Beginning to Make Progress against HIV
Wilfert
NEJM 1996;335:1678-1680.
FULL TEXT  

Preventing Perinatal HIV Transmission-Reply
Simonds et al.
JAMA 1996;276:779-780.
ABSTRACT  

Perinatal HIV Infection
Cohn and Klein
JAMA 1996;276:527-528.
ABSTRACT  

Antiretroviral Therapy for HIV Infection in 1996: Recommendations of an International Panel
Carpenter et al.
JAMA 1996;276:146-154.
ABSTRACT  

Perinatal HIV Infection: A Tale of Two States
JWatch Women's Health 1996;1996:17-17.
FULL TEXT  

Reducing Mother-to-Infant Transmission of HIV -- The Door Remains Open
Landers and Sweet
NEJM 1996;334:1664-1665.
FULL TEXT  

PROGRESS AND CHALLENGES IN PREVENTING PERINATAL HIV
JWatch General 1996;1996:2-2.
FULL TEXT  

Preventing Perinatal HIV Infection: How Far Have We Come?
Simonds and Rogers
JAMA 1996;275:1514-1515.
ABSTRACT